Nexesta Fe
These highlights do not include all the information needed to use NEXESTA Fe safely and effectively. See Full Prescribing Information for NEXESTA Fe. NEXESTA Fe (norethindrone and ethinyl estradiol tablets (chewable) and ferrous fumarate tablets (chewable)) for oral use Initial U.S. Approval: 1975
Approved
Approval ID
6eb8f7b6-4b8e-4bad-800a-b2f3b36c3413
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 4, 2021
Manufacturers
FDA
Aurobindo Pharma Limited
DUNS: 650082092
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norethindrone and ethinyl estradiol and ferrous fumarate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code65862-926
Application NumberANDA207535
Product Classification
M
Marketing Category
C73584
G
Generic Name
norethindrone and ethinyl estradiol and ferrous fumarate
Product Specifications
Effective DateDecember 4, 2021
FDA Product Classification